Stanford University
Showing 6,801-6,850 of 13,044 Results
-
John D. Louie, MD
Clinical Professor, Radiology
Current Research and Scholarly InterestsMy research interests focus on interventional oncology which include radioembolization (SIR Spheres and Theraspheres), chemoembolization, and ablation.
-
David Love
Strategy and Operations Lead, Technology & Digital Solutions
BioEverything should be as simple as it can be, but not simpler.
-- Albert Einstein (attributed)
It can scarcely be denied that the supreme goal of all theory is to make the irreducible basic elements as simple and as few as possible without having to surrender the adequate representation of a single datum of experience.
-- Albert Einstein (actual) -
Alarice Cheng-Yi Lowe
Associate Professor of Pathology
BioDr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of new technology to improve clinical and molecular diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.
-
Anson Lowe
Associate Professor of Medicine (Gastroenterology and Hepatology), Emeritus
Current Research and Scholarly InterestsThe laboratory is focused on the relationship between injury, wound healing, and cancer. Esophageal, gastric, and pancreatic cancers are a focus. We are particularly interested in the regulation of cell signaling by EGFR, the EGF receptor. In addition to cancer pathogenesis, active projects include the development of new diagnostic assays and drugs.
-
Chenery Lowe
Postdoctoral Scholar, Biomedical Ethics
BioChenery Lowe, Ph.D., CGC, is a genetic counselor and healthcare communication researcher. She received her ScM in Genetic Counseling from the Johns Hopkins University/ National Institutes of Health Genetic Counseling Training Program in 2018. Chenery received her Ph.D. in Social and Behavioral Sciences from Johns Hopkins Bloomberg School of Public Health in 2022, where she later served as an assistant scientist and academic director for the JHU/NIH genetic counseling program. Clinically, she has provided genetic counseling in immunology and adult oncology settings. She has taught graduate-level courses on interpersonal communication in health care, health literacy, and social and behavioral research in genetic counseling. Her research interests are in the areas of patient-provider communication, health equity, implicit bias, communication skills training interventions, and the ethics of interpersonal influence in medical care.
-
Henry J. Lowe, MD
Associate Professor of Medicine (General Medical Disciplines) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMy research in the field of biomedical informatics over the past 30 years has focused on the development of novel uses of information technology and computer science to improve human health. My current interests include the Electronic Health Record (EHR), biomedical knowledge representation, Internet applications in healthcare, clinical data warehouses, clinical data and text mining, academic social networking and the use of information technology to support clinical and translational research.
-
Norman Lowenbraun
Member, Cardiovascular Institute
BioDr Lowenbraun has been a practicing cardiologist in the Bay Area for over 25 years, having moved here after receiving his medical and specialty training on the East Coast. He believes offering the personal care of a community setting and empowering the patient in their healthcare decisions, combined with the resources of Stanford Hospital , offers his patients the best of both worlds.
-
Robert Lowsky
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation.
-
Bingwei Lu
Professor of Pathology
Current Research and Scholarly InterestsWe are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimers and Parkinsons diseases. We are using both Drosophila and mammalian models to address these fundamental questions.
-
Lu,Guolan
Assistant Professor of Urology
Current Research and Scholarly InterestsThe Lu Lab develops and integrates AI, spatial multi-omics, and advanced imaging to understand and model how cells, tissues, and therapeutic agents interact in their native spatial context, and how these interactions drive disease progression and treatment response.
-
Janice Lu
Clinical Professor, Medicine - Oncology
BioDr. Janice Lu is Clinical Professor of Medicine in the Division of Medical Oncology at Stanford University School of Medicine. She specializes in the treatment of breast cancer, with expertise in hormone receptor–positive and HER2-positive disease, antibody-drug conjugates, and immunotherapy. Dr. Lu has led and contributed to multiple clinical trials, including playing a key role in the EMERALD trial, which resulted in FDA approval of the first oral SERD for ESR1-mutated ER+/HER2- metastatic breast cancer. Her translational research focuses on liquid biopsy, epigenetics, AI and multiomics approaches to treatment resistance. She has chaired national sessions on precision oncology and holds leadership roles with NRG Oncology and ASCO, including Vice-Chair of the NRG Immunotherapy Subcommittee and Track Leader for ASCO’s Developmental Therapeutics and Targeted Therapy Education Program. She has also served on committees for the National Comprehensive Cancer Network (NCCN) and the Southwest Oncology Group (SWOG).
Dr. Lu completed her Hematology and Oncology fellowship at New York University School of Medicine and earned a PhD in epigenetics under the mentorship of late Dr. David Allis, a pioneer in the field and 2018 Lasker Laureate. Prior to joining Stanford, she was Director of Breast Medical Oncology and led the Circulating Tumor Cell (CTC) Core Lab at Northwestern University Feinberg School of Medicine, before returning to the Bay Area to be with her family and to further expand research and patient-centered care. -
Junjie Lu
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2023
BioJunjie's research is centered on the social determinants of minority health, epidemiological methods, and clinical effectiveness. He is deeply committed to understanding the health disparities faced by minority populations. His clinical background helps bridge the gap between research and practical application, aiming to improve healthcare outcomes in real-world settings.
Junjie Lu earned a Master of Public Health degree from the Harvard T.H. Chan School of Public Health, where he concentrated on Health and Social Behavior. He also holds an MBBS and an MS from Shanghai University of Traditional Chinese Medicine. Junjie gained practical experience as an intern doctor at a university hospital for two years, during which he led a pilot randomized controlled trial on the effects of acupuncture on depressive symptoms. -
Sydney X. Lu
Assistant Professor of Medicine (Hematology)
BioSydney Lu is an assistant professor and physician-scientist in the Division of Hematology, Department of Medicine with a broad interest in both normal and abnormal RNA processing in the context of normal physiology and disease states. The laboratory studies translational questions regarding the mechanistic basis of RNA processing abnormalities in malignant blood disorders, their implications for leukemogenesis and cancer biology, as well as resultant therapeutic opportunities.
As a physician, Sydney’s group is particularly focused on dissecting RNA processing abnormalities in primary patient samples and disease-relevant preclinical model systems. Lab members employ a variety of ‘wet-lab’ and computational approaches to study transcriptome abnormalities in (1) states of immune dysfunction, (2) myeloid blood cancers such as myelodysplastic syndromes and acute myeloid leukemia, and (3) lymphoid blood cancers such as chronic lymphocytic leukemia. Additional projects are focused on novel therapeutics, including multiple targeted agents which modulate RNA processing, for the selective treatment of these diseases.
Sydney’s research is/has been supposed by grant funding from the National Cancer Institute, Parker Institute for Cancer Immunotherapy, Leukemia & Lymphoma Society, Aplastic Anemia & Myelodysplastic Syndromes International Foundation, the American Society for Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, the Paula and Rodger Riney Foundation, the Doris Duke Charitable Foundation, The Gabrielles Angel Foundation for Cancer Research, and the Stanford Cancer Institute. -
Wan-Jin Lu
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioDr. Wan-Jin Lu is a Research Scientist in Dr. Phil Beachy's lab. Wan-Jin grew up in Taiwan, obtained her B.S. in Zoology at National Taiwan University and completed her PhD in Genetics and Development at UT Southwestern in the lab of Dr. John Abrams. Her Ph.D. research involved the identification of the evolutionary conserved function of the tumor suppressor gene p53 that ensures the quality control of germ cells. She then moved to the Bay Area, where she was a Damon Runyon Postdoctoral Fellow in the Institute of Stem Cell Biology and Regenerative Medicine in the Beachy lab. Her work currently focuses on understanding the function of Hedgehog signaling in taste receptor cell homeostasis and delineating the mechanisms of taste receptor regeneration after chemotherapy-induced loss.
Since 2017, she has been collaborating with Tabula Muris And Tabula Sapiens Consortium to investigate taste receptor stem cell renewal and regeneration in the Beachy lab. Her work has received funding support from California Institute of Regenerative Medicine (CIRM), Thomas and Stacey Siebel Foundation, and NIH (R21 and R01). -
Ying Lu
Professor of Biomedical Data Science and, by courtesy, of Epidemiology
Current Research and Scholarly InterestsBiostatistics, clinical trials, statistical evaluation of medical diagnostic tests, radiology, osteoporosis, meta-analysis, medical decision making
-
Anna Luan, MD, MS
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Luan is a fellowship-trained plastic and reconstructive surgeon and hand and upper extremity surgeon with Stanford Health Care. She is a clinical assistant professor in the Department of Surgery, Division of Plastic & Reconstructive Surgery at Stanford University School of Medicine.
Dr. Luan specializes in diagnosing and treating hand and peripheral nerve disorders. She treats issues such as fractures, instability, soft tissue injuries, degenerative conditions, spasticity, nerve compression, and peripheral nerve injuries. She also treats many other conditions that cause pain or other problems with the hands.
In addition, Dr. Luan has expertise in treating patients with upper and lower extremity amputations. Amputations can result from trauma, tumors, vascular disease, or infection. Dr. Luan specializes in surgeries to help prevent or treat pain and to maximize function in upper and lower extremity amputations. She takes a personalized approach to patient care, considering each individual’s condition, concerns, and goals.
Dr. Luan’s research interests include innovation and translational research, which applies the results of scientific research to treating patients or preventing illness. She also researches clinical outcomes and global surgery. Additionally, Dr. Luan’s research explores how technologies such as artificial intelligence (AI), machine learning, and deep learning can be used to improve patient care.
Dr. Luan has published in many peer-reviewed journals, including the Journal of Hand Surgery and Plastic and Reconstructive Surgery. She also serves as a reviewer for multiple journals. She has authored textbook chapters and delivered presentations at symposiums and conferences nationally and worldwide.
Dr. Luan is an affiliated faculty member of the Stanford Center for Artificial Intelligence in Medicine and Imaging. The center focuses on responsible innovation and research in medical AI applications. She is also a member of the American Society of Plastic Surgeons, American Association for Hand Surgery, American Society for Surgery of the Hand, and California Society of Plastic Surgeons. -
Anniek Frederike Lubberding
Affiliate, Pediatrics - Endocrinology
BioHuman biologist and (electro-)physiologist bridging cardiac and pancreatic research to improve treatment of diabetes and heart disease.
-
Stephen Luby
Lucy Becker Professor of Medicine, Senior Fellow at the Woods Institute for the Environment, Freeman Spogli Institute for International Studies and Professor, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Luby’s research interests include identifying and interrupting environmental pathways of disease in low- and middle-income countries.
-
Anthony R. Lucas
Postdoctoral Scholar, Psychiatry
BioAnthony R. Lucas, PsyD is a postdoctoral fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. He provides psychotherapy in the ADAPT Clinic for Mood and Anxiety Disorders and the Addiction Medicine Dual Diagnosis Clinic.
In the ADAPT Clinic, Dr. Lucas focuses on diagnostic formulation and psychotherapy for mood and anxiety disorders, drawing on structured and transdiagnostic approaches while attending to the psychological and contextual factors that shape symptom presentation and recovery.
In the Addiction Medicine Dual Diagnosis Clinic, he provides psychotherapy for individuals with substance use disorders and behavioral addictions and co-occurring psychiatric conditions, centering collaborative treatment planning and addressing the interplay between addiction, trauma, and mental health.
Dr. Lucas also provides clinical supervision to graduate student trainees at the Palo Alto VA, with a focus on case formulation, clinical reasoning, and reflective professional development.
Dr. Lucas completed his APA-accredited doctoral internship in Clinical Psychology at Kaiser Permanente Northern California, Addiction Medicine & Recovery Services, Walnut Creek. -
Kristine Luce
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Luce is a Psychologist and Clinical Professor in the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine. She received her doctorate in Clinical Psychology from Kent State University. She completed a pre-doctoral internship at the Seattle Veterans Hospital and a post-doctoral research fellowship at Stanford University in the Department of Psychiatry and Behavioral Sciences. Dr. Luce has clinical and research experience with eating-related disorders and is the Co-Director of the Stanford Adult Eating Disorders Program. In addition, Dr. Luce treats anxiety and mood disorders and has specialized clinical training in Cognitive Behavioral Therapy and Dialectical Behavioral Therapy.
-
Linda Lucian
Sr. Manager, Translational Programs, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordPrimary Biodesign role of Translation Project Manager for the eight internal funding programs administered through Biodesign. Stanford- Coulter TRPP Award, NIH funded Spectrum-Medtech Award, Wu Tsai Neuroscience:Translate Award, Innovation Fellowship Extension Award, Innovation Course Extension Award, Faculty Fellowship Award, NEXT Award, and Robert Howard Next Step Award.
